Immunomedics Announces Third Quarter Fiscal 2016 Results and Clinical Program Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. GRMN
8. VRSK
9. YUM
10. TXNM

Go back to Immunomedics Announces Third Quarter Fiscal 2016 Results and Clinical Program Developments

Immunomedics (IMMU) Misses Q3 EPS by 2c

May 4, 2016 6:36 PM EDT

Immunomedics (NASDAQ: IMMU) reported Q3 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $2.13 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.

... More